Clinical Trial Update: Beclomethasone Dipropionate HFA in Adult and Adolescent Subjects With Mild to Moderate Persistent Asthma [Phase 3]

View source ↗

Summary

Phase 3 trial investigating Beclomethasone Dipropionate HFA for mild to moderate persistent asthma was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• Beclomethasone Dipropionate HFA (Beclomethasone Dipropionate)

Snippet

Sponsor: Adamis Pharmaceuticals Corporation | Conditions: Asthma | Phase 3 | Status: WITHDRAWN